[go: up one dir, main page]

DE3468104D1 - New aryloxypropanolamine derivatives, process for the preparation thereof, pharmaceutical compositions and therapeutic use - Google Patents

New aryloxypropanolamine derivatives, process for the preparation thereof, pharmaceutical compositions and therapeutic use

Info

Publication number
DE3468104D1
DE3468104D1 DE8484100085T DE3468104T DE3468104D1 DE 3468104 D1 DE3468104 D1 DE 3468104D1 DE 8484100085 T DE8484100085 T DE 8484100085T DE 3468104 T DE3468104 T DE 3468104T DE 3468104 D1 DE3468104 D1 DE 3468104D1
Authority
DE
Germany
Prior art keywords
hydrogen
preparation
pharmaceutical compositions
lower alkyl
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484100085T
Other languages
English (en)
Inventor
Cesare Casagrande
Massimo Nicola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierrel SpA
Original Assignee
Pierrel SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel SpA filed Critical Pierrel SpA
Application granted granted Critical
Publication of DE3468104D1 publication Critical patent/DE3468104D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8484100085T 1983-01-21 1984-01-06 New aryloxypropanolamine derivatives, process for the preparation thereof, pharmaceutical compositions and therapeutic use Expired DE3468104D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19219/83A IT1193608B (it) 1983-01-21 1983-01-21 Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico

Publications (1)

Publication Number Publication Date
DE3468104D1 true DE3468104D1 (en) 1988-01-28

Family

ID=11155887

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484100085T Expired DE3468104D1 (en) 1983-01-21 1984-01-06 New aryloxypropanolamine derivatives, process for the preparation thereof, pharmaceutical compositions and therapeutic use

Country Status (6)

Country Link
US (1) US4579861A (de)
EP (1) EP0116825B1 (de)
JP (1) JPS59139362A (de)
AT (1) ATE31410T1 (de)
DE (1) DE3468104D1 (de)
IT (1) IT1193608B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL135487A (en) 2000-04-05 2005-07-25 Cupron Corp Antimicrobial and antiviral polymeric materials and a process for preparing the same
US7296690B2 (en) 2002-04-18 2007-11-20 The Cupron Corporation Method and device for inactivating viruses
US7364756B2 (en) 2003-08-28 2008-04-29 The Cuprin Corporation Anti-virus hydrophilic polymeric material
US7480393B2 (en) 2003-11-19 2009-01-20 Digimarc Corporation Optimized digital watermarking functions for streaming data
DE602005015475D1 (de) 2004-11-09 2009-08-27 Cupron Corp Verfahren und materialien für die hautpflege
US9751830B2 (en) 2010-03-15 2017-09-05 The Trustees Of The University Of Pennsylvania Inhibitors of the tumor necrosis factor receptor complex
IT202100000782A1 (it) 2021-01-18 2022-07-18 Procos Spa Processo per la sintesi di imepitoina
EP4553066A1 (de) 2023-11-10 2025-05-14 Justesa Imagen S.A.U. Verbessertes verfahren zur synthese von imepitopin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
DE2644833A1 (de) * 1976-10-05 1978-04-20 Boehringer Sohn Ingelheim Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung
DK193181A (da) * 1980-06-05 1981-12-06 Hoffmann La Roche Fremgangmaade til fremstilling af imidazolderivater
US4319032A (en) * 1980-06-06 1982-03-09 Alcolac Inc. Derivatives of aminoalkyl alkylene ureas

Also Published As

Publication number Publication date
EP0116825B1 (de) 1987-12-16
IT1193608B (it) 1988-07-21
US4579861A (en) 1986-04-01
ATE31410T1 (de) 1988-01-15
JPS59139362A (ja) 1984-08-10
EP0116825A1 (de) 1984-08-29
IT8319219A0 (it) 1983-01-21

Similar Documents

Publication Publication Date Title
NO823836L (no) Fremgangsmaate ved fremstilling av antifibrinolytisk aktive forbindelser.
IE840182L (en) Des-proline vasopressin antagonists
DE3468104D1 (en) New aryloxypropanolamine derivatives, process for the preparation thereof, pharmaceutical compositions and therapeutic use
JPS56115769A (en) Piperazine derivative and its preparation
ZA826755B (en) Substituted phenylsulfonylurea derivatives,a process for their preparation and their use as herbicides,and new intermediate products for their preparation
IL67812A (en) Indanylbenzamide derivatives,process for the preparation thereof and fungicidal compositions comprising the same
JPS5663966A (en) Pyrimidine derivative and its preparation
EP0211272A3 (de) Azoverbindung und dieselbe enthaltende farbige Zusammensetzung
EP0467662A3 (en) Liquid crystal racemic mixture, liquid crystal composition and liquid crystal element, process for manufacturing and uses thereof
IE802684L (en) Quinoline derivatives
ES8606228A1 (es) Un procedimiento para separar los antipodas opticos de 1-pi-ridil-alquil-4-aril-piperazinas
ES8306143A1 (es) "procedimiento para la preparacion de compuestos de 1,5-difenilpirazolin-3-ona".
AU550340B2 (en) Dibenzazepine derivatives
JPS51141896A (en) Process for preparing fused ring triazoropyrimidine derivatives
DE3264708D1 (en) 4-aryloxy-1,2,3,4-tetrahydroisoquinolines, and intermediates, a process for preparing the same, a pharmaceutical composition containing the same and their use as medicaments
ES8106703A1 (es) Un procedimiento de preparacion de una 7-acilindolin-2-ona
ES8403913A1 (es) Un procedimiento para la preparacion de derivados de 3-cxa-1-azabiciclo (4,2,0) octano.
ES446325A1 (es) Procedimiento para preparar tieno-(3,2-c)-piridina y deriva-dos de la misma.
DE3362036D1 (en) Ketene-o,o-acetates and process for their preparation
FI821504A0 (fi) Aminocyklopentanolsyror och -estrar och deras framstaellning och farmaceutiska komposition
JPS51136653A (en) Process for preparing novel organophosphorous compounds
AU547599B2 (en) Tricyclic compounds
PL245632A1 (en) Process for preparing novel heterocyclic compounds
ES2001701A6 (es) Un metodo para preparar compuesto de benzoilurea
ZA823113B (en) New delta 1-pyrroline thiolactim ethers and a process for their preparation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee